Connect with us

Life Sciences

M&A: Commure Acquires Mount Sinai Spinoff Rx.Health

What You Should Know:  – Commure, Inc., a healthcare technology company acquires intelligent clinical automation platform Rx.Health and is now part…

Published

on

This article was originally published by HIT Consultant
M&A: Commure Acquires Mount Sinai Spinoff Rx.Health

What You Should Know: 

Commure, Inc., a healthcare technology company acquires intelligent clinical automation platform Rx.Health and is now part of its suite of solutions as Commure Engage. Financial details of the acquisition were not disclosed. 

– Spun out of Mount Sinai Health System, Rx.Health offers a low-code, no-code clinical care coordination platform that helps health systems, payors, and life science organizations streamline their end-to-end patient care efforts, from patient identification and outreach through personalized care journeys to ongoing care monitoring and alerts. 

Now Available as Commure Engage

Rx.Health serves leading U.S. health organizations including Yale New Haven Health and UnitedHealthcare, the Rx.Health platform combines multiple digital therapeutics, automated nudges, devices, and AI analytics to support patients wherever their care journey takes them. 

Key benefits of leveraging RxHealth include: 

– Boosting system revenue by encouraging preventative care visits, lowering the risk for no-shows and costly patient readmissions, and mitigating patient leakage.

– Improving care quality and access by making it easier than ever for care providers to educate, collaboratively treat, monitor, and follow up on individual care needs.

– Alleviating workforce fatigue through automated patient outreach, freeing clinicians and staff up to focus less on burdensome administrative tasks and more on providing care.

“As healthcare providers grapple with the growing weight of administrative work tax, engaging patients as active collaborators in — rather than passive consumers of — their unique care journey will be one of the keys to unlocking a brighter future for our industry,” said Tanay Tandon, CEO of Commure. “We’re thrilled to welcome Rx.Health to the Commure portfolio, and, together, power unparalleled clinical experiences and financial outcomes for hospitals and health systems across the country.”

therapeutics


devices

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending